Drug Shortage Report for JALYN

Last updated on 2020-03-26 History
Report ID 106829
Drug Identification Number 02372010
Brand name JALYN
Common or Proper name dutasteride/tamsulosin hydrochloride modified release capsules
Company Name GLAXOSMITHKLINE INC
Market Status MARKETED
Active Ingredient(s) TAMSULOSIN HYDROCHLORIDE DUTASTERIDE
Strength(s) 0.4MG 0.5MG
Dosage form(s) CAPSULE (IMMEDIATE AND EXTENDED RELEASE)
Route of administration ORAL
Packaging size 30's
ATC code G04CA
ATC description DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-02-26
Estimated end date 2020-03-31
Actual end date 2020-03-25
Shortage status Resolved
Updated date 2020-03-26
Company comments
Health Canada comments
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-02-21 English Compare
v2 2020-02-21 French Compare
v3 2020-02-26 English Compare
v4 2020-02-26 French Compare
v5 2020-02-27 English Compare
v6 2020-03-25 English Compare
v7 2020-03-25 French Compare
v8 2020-03-26 English Compare